🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Sixty % of CML patients treated by Imatinib mesylate achieved a major cytog...
Status
Unknown
Location
Franck NICOLINI
Start Date
2004-03
Trial ID
NCT00146913
Treatments Being Tested
The Imatinib Mesylate at a dose of 400 mg / day is the standard treatment f...
Status
Terminated
Location
Institut Bergonié
Start Date
2009-07
Trial ID
NCT01827930
Treatments Being Tested
This phase II trial is studying how well combination chemotherapy with or w...
Status
Completed
Location
Children's Oncology Group
Start Date
2002-10
Trial ID
NCT00022737
Treatments Being Tested
Objectives: * To determine the response rate and duration of response with...
Status
Terminated
Location
UT MD Anderson Cancer Center
Start Date
2006-12
Trial ID
NCT00415909
Treatments Being Tested
This phase II trial studies how well etoposide, prednisone, vincristine sul...
Status
Withdrawn
Location
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium
Start Date
2018-07-01
Trial ID
NCT02538926
The goal of this observational study is to evaluate the overall survival be...
Status
Completed
Location
The First Affiliated Hospital of Sun Yat-sen University
Start Date
2002-01-01
Trial ID
NCT06038552
Imatinib (IM) has significantly enhanced the prognosis of patients (pts) wi...
Status
Completed
Location
The First Affiliated Hospital of Sun Yat-sen University
Start Date
2017-07-01
Trial ID
NCT06628739
Treatments Being Tested
The purpose of this study is to determine the efficacy of imatinib mesylate...
Status
Completed
Location
Massachusetts General Hospital
Start Date
2007-12
Trial ID
NCT00677092
Treatments Being Tested
This prospective study is performed to identify safer and more concrete ind...
Status
Unknown
Location
Seoul St. Mary's Hospital
Start Date
2010-06
Trial ID
NCT01564836
Treatments Being Tested